Skip to main content
SpringerLink
Log in
Book cover

Brachytherapy pp 63–69Cite as

Ocular Brachytherapy

  • Chapter
  • First Online:

  • 1284 Accesses

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

Episcleral plaque brachytherapy (EPB) has been utilized since the first half of the last century to treat intraocular tumors [1]. The two most common indications for EPB are ocular/choroidal melanoma (CM) and retinoblastoma. Although the techniques are similar, the focus of this chapter will be on the treatment of CM.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Moore R (1930) Choroidal sarcoma treated by the intraocular insertion of radon seeds. Br J Ophthalmol 14:145–156

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Singh AD, Bergman L, Seregard S (2005) Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am 18:75–84

    Article  PubMed  Google Scholar 

  3. Shields JA (1878) Accuracy and limitations of the 32P test in the diagnosis of ocular tumors: an analysis of 500 cases. Ophthalmology 85:950–966

    Article  Google Scholar 

  4. Augusburger JJ, Shields JA (1984) Fine needle aspiration biopsy of solid intraocular tumors: indications, instrumentation and techniques. Ophthalmic Surg 15:34–40

    Google Scholar 

  5. Stallard HR (1966) Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol 50:147–155

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Finger PT, Bufa A, Mishra S et al (1994) Palladium 103 plaque radiotherapy for uveal melanoma: clinical experience. Ophthalmology 101:256–263

    Article  CAS  PubMed  Google Scholar 

  7. Collaborative Ocular Melanoma Study Group (1995) Ch 12: Radiation therapy. In: National technical information service (NTIS). COMS manual of procedures, Springfield, pp PB95–PB179693

    Google Scholar 

  8. Collaborative Ocular Melanoma Study Group (2006) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol 124:1684–1693

    Article  Google Scholar 

  9. Collaborative Ocular Melanoma Study Group (2002) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy: COMS report No. 19. Ophthalmology 109:2197–2206

    Article  Google Scholar 

  10. Collaborative Ocular Melanoma Study Group (2001) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: I. Visual acuity after 3 years: COMS Report No. 16. Ophthalmology 108:348–366

    Article  Google Scholar 

  11. Lommatzsch PK (1987) Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas. Twenty years’ experience. Am J Clin Oncol 10:146–151

    Article  CAS  PubMed  Google Scholar 

  12. Packer S, Rotman M (1980) Radiotherapy of choroidal melanoma with iodine-125. Ophthalmology 87:582–590

    Article  CAS  PubMed  Google Scholar 

  13. Sealy R, le Roux PL, Rapley F et al (1976) The treatment of ophthalmic tumors with low-energy sources. Br J Radiol 49:551–554

    Article  CAS  PubMed  Google Scholar 

  14. Finger PT, Chin KJ, Duvall G et al (2009) Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients. Ophthalmology 116:790–796

    Article  PubMed  Google Scholar 

  15. Rivard MJ, Melhus CS, Sioshansi S et al (2008) The impact of prescription depth, dose rate, plaque size, and source loading on the central axis using 103Pd, 1251 and 131Cs. Brachytherapy 7:327–335

    Article  PubMed  Google Scholar 

  16. Finger PT (1997) Radiation therapy for choroidal melanoma. Surg Ophthalmol 42:215–232

    Article  CAS  Google Scholar 

  17. Leonard KL, Gagne NL, Mignano JE et al (2011) A 17 year retrospective study of institutional result or eye plaque brachytherapy of uveal melanoma using (125)I, (103)Pd., and (131)Cs and historical perspective. Brachytherapy 10:331–339

    Article  PubMed  Google Scholar 

  18. Vakulenko MP, Dedenkov AN, Brovkina AF et al (1980) Results of beta-therapy of choroidal melanoma. Med Radiol (Mosk) 25:73–74

    CAS  Google Scholar 

  19. Brovkina AF, Zarubei GD, Val’skii VV (1997) Criteria for assessing the efficacy of brachytherapy of uveal melanomas, complications of therapy and there prevention. Vestn Ofalmol 113:14–16

    CAS  Google Scholar 

  20. Murakami N, Suzuki S, Ito Y et al (2012) Ruthenium plaque therapy (RPT) for retinoblastoma. Int J Radiat Oncol Biol Phys 84:59–65

    Article  PubMed  Google Scholar 

  21. Nag S, Quivey JM, Earle JD et al (2003) The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys 56(2):544–555

    Article  PubMed  Google Scholar 

  22. American Brachytherapy Society – Opthalmic Oncology Task Force (2014) The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. Brachytherapy 13(1):1–14

    Article  Google Scholar 

  23. Rivard MJ, Chiu-Tsao ST, Finger PT et al (2011) Comparison of dose calculation methods for brachytherapy of intraocular tumors. Med Phys 38:306–316

    Article  PubMed  PubMed Central  Google Scholar 

  24. Chiu-Tsao S, Astrahan MA, Finger PT et al (2012) Dosimetry of 125I and 103Pd COMS eye plague for intraocular tumor: report of Task Group 129 by the AAPM and ABS. Med Phys 2396:6161–6184

    Article  Google Scholar 

  25. Ferry AP (1964) Lesions mistaken for malignant melanoma of the posterior uvea: a clinical pathologic analysis of 100 cases with ophthalmoscopically visible lesions. Arch Ophthalmol 72:463–469

    Article  CAS  PubMed  Google Scholar 

  26. Albert DM, Marcus DM (1990) Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS Report No. 1. Arch Ophthalmol 108:1268–1273

    Article  Google Scholar 

  27. Harbour JW (2009) Molecular prognostic testing and individualized patient care in uveal melanoma. Am J Ophthalmol 148:823–829

    Article  PubMed  PubMed Central  Google Scholar 

  28. Prescher G, Bornfeld N, Hirsche H et al (1996) Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347:1222–1225

    Article  CAS  PubMed  Google Scholar 

  29. Uveal melanoma (2009) In: Edge SE, Byrd DR, Compton CC et al (eds) The AJCC cancer staging manual. 7th ed. New York: London, Springer, pp 547–559

    Google Scholar 

  30. Finger PT (2000) Tumor location affects the incidence of cataract and retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol 84:1068–1070

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Finger PT, Chin KJ, Yu GP (2010) Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma. Am J Ophthalmol 149:608–615

    Article  PubMed  Google Scholar 

  32. Finger PT, Chin KJ, Yu GP et al (2010) Risk factors for cataract after palladium-103. Ophthalmic plaque radiation therapy. Int J Radiat Oncol Biol Phys 80:800–806

    Article  PubMed  Google Scholar 

  33. Quivey JM, Char DH, Phillips TL et al (1993) High intensity 125-iodine (125I) plaque treatment of uveal melanoma. Int J Radiat Oncol Biol Phys 26:613–618

    Article  CAS  PubMed  Google Scholar 

  34. Shields CL, Demirci H, Dai V et al (2005) Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma. Retina 25:868–874

    Article  PubMed  Google Scholar 

  35. Shah SU, Shields CL, Bianciotto CG et al (2014) Intravitreal bevacizumab injection at 4 month intervals for prevention of macular edema following plaque radiotherapy of uveal melanoma. Ophthalmology 121:269–275

    Article  PubMed  Google Scholar 

  36. Evans MDC, Astrahan MA, Bate R (1993) Tumor localization using fundus view photograph for episcleral plaque therapy. Med Phys 20:769–775

    Article  CAS  PubMed  Google Scholar 

  37. Diener-West M, Reynolds SM, Agugliano DJ et al (2005) Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol 123(12):1639–1643

    Article  PubMed  Google Scholar 

  38. Robertson DM, Earle J, Anderson JA (1983) Preliminary observations regarding the use of iodine-125 in the management of choroidal melanoma. Trans Ophthalmol Soc U K 103(pt2):155–160

    PubMed  Google Scholar 

  39. Houdek PV, Schwade JG, Medina AJ et al (1989) MR technique for localization and verification procedures in episcleral brachytherapy. Int J Radiat Oncol Biol Phys 17:1111–1114

    Article  CAS  PubMed  Google Scholar 

  40. Collaborative Ocular Melanoma Study Group (2007) Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COM Report No 27. Ophthalmology 114(7):1363–1371

    Article  Google Scholar 

  41. Collaborative Ocular Melanoma Study Group (2009) I-125 brachytherapy for choroidal melanoma: photographic & angiographic abnormalities. Collaborative Ocular Melanoma Study: COMS Report No 30. Ophthalmology 116(1):106–115

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Allegheny Health Network Cancer Institute, Allegheny General Hospital, Pittsburgh, PA, USA

    Stephen Karlovits MD

  2. Radiation Oncology, Temple University School of Medicine, Pittsburgh, PA, USA

    Stephen Karlovits MD

  3. Department of Ophthalmology, Allegheny Ophthalmic and Orbital Associates, Drexel University College of Medicine, Pittsburgh, PA, USA

    Thierry Verstraeten MD

Authors
  1. Stephen Karlovits MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thierry Verstraeten MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen Karlovits MD .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA

    Paolo Montemaggi

  2. AlleghenyHealthNetworkCancer Ins,Divi RO, Drexel Univ, College of Medi, Pittsburgh, Pennsylvania, USA

    Mark Trombetta

  3. Dept Radiation Oncology, Drexel Univ, College of Medi, Philadelphia, Pennsylvania, USA

    Luther W. Brady

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Karlovits, S., Verstraeten, T. (2016). Ocular Brachytherapy. In: Montemaggi, P., Trombetta, M., Brady, L. (eds) Brachytherapy. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/978-3-319-26791-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26791-3_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26789-0

  • Online ISBN: 978-3-319-26791-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation